 of prescriptions that in this country are controlled by just three companies. That's not competition. And PBMs are causing drug prices to remain high and to go even higher. Finally, after nine and a half years, or I should say seven and a half years, two years ago, the FTC agreed to implement a study on the impact of PBMs.